Private Management Group Inc. Sells 15,980 Shares of Tenet Healthcare Corporation $THC

Private Management Group Inc. lessened its stake in Tenet Healthcare Corporation (NYSE:THC) by 18.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 68,607 shares of the company’s stock after selling 15,980 shares during the period. Private Management Group Inc.’s holdings in Tenet Healthcare were worth $13,930,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in THC. William B. Walkup & Associates Inc. acquired a new position in Tenet Healthcare in the 3rd quarter valued at approximately $32,000. Westside Investment Management Inc. increased its position in shares of Tenet Healthcare by 100.0% during the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after purchasing an additional 96 shares during the period. Trust Co. of Vermont acquired a new position in shares of Tenet Healthcare in the third quarter valued at $41,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare in the second quarter worth $35,000. Finally, Geneos Wealth Management Inc. increased its holdings in Tenet Healthcare by 50.9% in the 2nd quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock valued at $46,000 after buying an additional 89 shares during the period. 95.44% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Paola M. Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the transaction, the executive vice president directly owned 29,291 shares of the company’s stock, valued at $6,983,853.13. The trade was a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Thomas W. Arnst sold 8,000 shares of the company’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the transaction, the executive vice president owned 12 shares in the company, valued at approximately $2,866.20. This trade represents a 99.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 48,695 shares of company stock valued at $11,373,201. 0.81% of the stock is owned by corporate insiders.

Tenet Healthcare Stock Performance

NYSE THC opened at $227.79 on Friday. The firm has a market cap of $19.81 billion, a price-to-earnings ratio of 14.71, a PEG ratio of 1.11 and a beta of 1.39. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $247.21. The company has a 50 day moving average of $213.46 and a 200-day moving average of $203.99.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. During the same period in the prior year, the company earned $3.44 EPS. Tenet Healthcare’s revenue for the quarter was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, equities analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on THC. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. Jefferies Financial Group lifted their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Truist Financial upped their price objective on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Finally, KeyCorp raised their target price on Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Thursday, February 12th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Tenet Healthcare has an average rating of “Moderate Buy” and a consensus price target of $250.56.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.